These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

579 related articles for article (PubMed ID: 27791129)

  • 1. Cross-talk between amyloidogenic proteins in type-2 diabetes and Parkinson's disease.
    Horvath I; Wittung-Stafshede P
    Proc Natl Acad Sci U S A; 2016 Nov; 113(44):12473-12477. PubMed ID: 27791129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Islet Amyloid Polypeptide Promotes Amyloid-Beta Aggregation by Binding-Induced Helix-Unfolding of the Amyloidogenic Core.
    Ge X; Yang Y; Sun Y; Cao W; Ding F
    ACS Chem Neurosci; 2018 May; 9(5):967-975. PubMed ID: 29378116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of amyloidogenic proteins in pancreatic β cells from subjects with synucleinopathies.
    Martinez-Valbuena I; Amat-Villegas I; Valenti-Azcarate R; Carmona-Abellan MDM; Marcilla I; Tuñon MT; Luquin MR
    Acta Neuropathol; 2018 Jun; 135(6):877-886. PubMed ID: 29536165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane disruption and early events in the aggregation of the diabetes related peptide IAPP from a molecular perspective.
    Brender JR; Salamekh S; Ramamoorthy A
    Acc Chem Res; 2012 Mar; 45(3):454-62. PubMed ID: 21942864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of lysine residue of islet amyloid polypeptide in fibril formation, membrane binding, and inhibitor binding.
    Wu MH; Chan AC; Tu LH
    Biochimie; 2020 Oct; 177():153-163. PubMed ID: 32860895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. α-Synuclein promotes IAPP fibril formation in vitro and β-cell amyloid formation in vivo in mice.
    Mucibabic M; Steneberg P; Lidh E; Straseviciene J; Ziolkowska A; Dahl U; Lindahl E; Edlund H
    Sci Rep; 2020 Nov; 10(1):20438. PubMed ID: 33235246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis for the inhibition of truncated islet amyloid polypeptide aggregation by Cu(II): insights into the bioinorganic chemistry of type II diabetes.
    Rivillas-Acevedo L; Sánchez-López C; Amero C; Quintanar L
    Inorg Chem; 2015 Apr; 54(8):3788-96. PubMed ID: 25826050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonistic Activity of Naphthoquinone-Based Hybrids toward Amyloids Associated with Alzheimer's Disease and Type-2 Diabetes.
    Paul A; Viswanathan GK; Mahapatra S; Balboni G; Pacifico S; Gazit E; Segal D
    ACS Chem Neurosci; 2019 Aug; 10(8):3510-3520. PubMed ID: 31282646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo seeding and cross-seeding of localized amyloidosis: a molecular link between type 2 diabetes and Alzheimer disease.
    Oskarsson ME; Paulsson JF; Schultz SW; Ingelsson M; Westermark P; Westermark GT
    Am J Pathol; 2015 Mar; 185(3):834-46. PubMed ID: 25700985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-Molecular Heteroamyloidosis of Human Islet Amyloid Polypeptide.
    Kakinen A; Xing Y; Hegoda Arachchi N; Javed I; Feng L; Faridi A; Douek AM; Sun Y; Kaslin J; Davis TP; Higgins MJ; Ding F; Ke PC
    Nano Lett; 2019 Sep; 19(9):6535-6546. PubMed ID: 31455083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vitro Analysis of α-Synuclein Amyloid Formation and Cross-Reactivity.
    Horvath I; Rocha S; Wittung-Stafshede P
    Methods Mol Biol; 2018; 1779():73-83. PubMed ID: 29886528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleobindin 1 binds to multiple types of pre-fibrillar amyloid and inhibits fibrillization.
    Bonito-Oliva A; Barbash S; Sakmar TP; Graham WV
    Sci Rep; 2017 Feb; 7():42880. PubMed ID: 28220836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β-Hairpin of Islet Amyloid Polypeptide Bound to an Aggregation Inhibitor.
    Mirecka EA; Feuerstein S; Gremer L; Schröder GF; Stoldt M; Willbold D; Hoyer W
    Sci Rep; 2016 Sep; 6():33474. PubMed ID: 27641459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crosstalk Between Alpha-Synuclein and Other Human and Non-Human Amyloidogenic Proteins: Consequences for Amyloid Formation in Parkinson's Disease.
    Werner T; Horvath I; Wittung-Stafshede P
    J Parkinsons Dis; 2020; 10(3):819-830. PubMed ID: 32538869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyphenols in combination with β-cyclodextrin can inhibit and disaggregate α-synuclein amyloids under cell mimicking conditions: A promising therapeutic alternative.
    Gautam S; Karmakar S; Batra R; Sharma P; Pradhan P; Singh J; Kundu B; Chowdhury PK
    Biochim Biophys Acta Proteins Proteom; 2017 May; 1865(5):589-603. PubMed ID: 28238838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of islet amyloidosis toxicity in type 2 diabetes.
    Abedini A; Schmidt AM
    FEBS Lett; 2013 Apr; 587(8):1119-27. PubMed ID: 23337872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Islet amyloid polypeptide triggers α-synuclein pathology in Parkinson's disease.
    Meng L; Li Y; Liu C; Zhang G; Chen J; Xiong M; Pan L; Zhang X; Chen G; Xiong J; Liu C; Xu X; Bu L; Zhang Z; Zhang Z
    Prog Neurobiol; 2023 Jul; 226():102462. PubMed ID: 37150314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Causative factors for formation of toxic islet amyloid polypeptide oligomer in type 2 diabetes mellitus.
    Jeong HR; An SS
    Clin Interv Aging; 2015; 10():1873-9. PubMed ID: 26604727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational transitions of islet amyloid polypeptide (IAPP) in amyloid formation in vitro.
    Kayed R; Bernhagen J; Greenfield N; Sweimeh K; Brunner H; Voelter W; Kapurniotu A
    J Mol Biol; 1999 Apr; 287(4):781-96. PubMed ID: 10191146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Amyloid Forming Peptides Islet Amyloid Polypeptide and Amyloid β Interact at the Molecular Level.
    Wang Y; Westermark GT
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.